Abstract
Abstract In the manufacturing of parenterals such as injectables, multi-use technology and single-use technology are available, which have different advantages and disadvantages regarding cost, environment, quality or supply. As a part of the design methodology which considers the choice of these technologies as the prominent decision, this study proposes risk evaluation models for parenterals manufacturing processes. Novel evaluation indicators were developed for product quality and supply risks, which can be aggregated with other indicators, such as cost and environment, to produce a total score. Case study was performed to demonstrate the models following the activities of process synthesis, evaluation, sensitivity analysis, and decision-making. The result indicated that the process using single-use technology is superior when the weighting factors for cost, environment, quality and supply are equal.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.